These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Modifications of physical and functional integrity of the blood-brain barrier in an inducible mouse model of neurodegeneration. Taccola C; Barneoud P; Cartot-Cotton S; Valente D; Schussler N; Saubaméa B; Chasseigneaux S; Cochois V; Mignon V; Curis E; Lochus M; Nicolic S; Dodacki A; Cisternino S; Declèves X; Bourasset F Neuropharmacology; 2021 Jun; 191():108588. PubMed ID: 33940010 [TBL] [Abstract][Full Text] [Related]
47. 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity. Hartz AM; Mahringer A; Miller DS; Bauer B J Cereb Blood Flow Metab; 2010 Oct; 30(10):1742-55. PubMed ID: 20216549 [TBL] [Abstract][Full Text] [Related]
48. Transcytosis within PVN capillaries: a mechanism determining both hypertension-induced blood-brain barrier dysfunction and exercise-induced correction. Fragas MG; Cândido VB; Davanzo GG; Rocha-Santos C; Ceroni A; Michelini LC Am J Physiol Regul Integr Comp Physiol; 2021 Nov; 321(5):R732-R741. PubMed ID: 34549626 [TBL] [Abstract][Full Text] [Related]
49. Developmental changes of l-arginine transport at the blood-brain barrier in rats. Tachikawa M; Hirose S; Akanuma SI; Matsuyama R; Hosoya KI Microvasc Res; 2018 May; 117():16-21. PubMed ID: 29247719 [TBL] [Abstract][Full Text] [Related]
50. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. Cartwright TA; Campos CR; Cannon RE; Miller DS J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528 [TBL] [Abstract][Full Text] [Related]
51. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles. Saint-Pol J; Gosselet F; Duban-Deweer S; Pottiez G; Karamanos Y Cells; 2020 Apr; 9(4):. PubMed ID: 32244730 [TBL] [Abstract][Full Text] [Related]
52. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Hartz AM; Bauer B; Soldner EL; Wolf A; Boy S; Backhaus R; Mihaljevic I; Bogdahn U; Klünemann HH; Schuierer G; Schlachetzki F Stroke; 2012 Feb; 43(2):514-23. PubMed ID: 22116809 [TBL] [Abstract][Full Text] [Related]
53. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835 [TBL] [Abstract][Full Text] [Related]
54. Blood-brain barrier-restricted translocation of Olivera GC; Ross EC; Peuckert C; Barragan A Elife; 2021 Dec; 10():. PubMed ID: 34877929 [TBL] [Abstract][Full Text] [Related]
55. In Vivo Evaluation of BBB Integrity in the Post-stroke Brain. Zhang Y; Nozohouri S; Abbruscato TJ Methods Mol Biol; 2023; 2616():191-203. PubMed ID: 36715936 [TBL] [Abstract][Full Text] [Related]
56. Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries. Grygorowicz T; Dąbrowska-Bouta B; Strużyńska L Purinergic Signal; 2018 Dec; 14(4):385-393. PubMed ID: 30091000 [TBL] [Abstract][Full Text] [Related]
57. Brain-Specific Ultrastructure of Capillary Endothelial Glycocalyx and Its Possible Contribution for Blood Brain Barrier. Ando Y; Okada H; Takemura G; Suzuki K; Takada C; Tomita H; Zaikokuji R; Hotta Y; Miyazaki N; Yano H; Muraki I; Kuroda A; Fukuda H; Kawasaki Y; Okamoto H; Kawaguchi T; Watanabe T; Doi T; Yoshida T; Ushikoshi H; Yoshida S; Ogura S Sci Rep; 2018 Nov; 8(1):17523. PubMed ID: 30504908 [TBL] [Abstract][Full Text] [Related]
58. Myeloperoxidase and Septic Conditions Disrupt Sphingolipid Homeostasis in Murine Brain Capillaries In Vivo and Immortalized Human Brain Endothelial Cells In Vitro. Goeritzer M; Bernhart E; Plastira I; Reicher H; Leopold C; Eichmann TO; Rechberger G; Madreiter-Sokolowski CT; Prasch J; Eller P; Graier WF; Kratky D; Malle E; Sattler W Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050431 [TBL] [Abstract][Full Text] [Related]
59. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14771-6. PubMed ID: 23959870 [TBL] [Abstract][Full Text] [Related]
60. Gpr124 is essential for blood-brain barrier integrity in central nervous system disease. Chang J; Mancuso MR; Maier C; Liang X; Yuki K; Yang L; Kwong JW; Wang J; Rao V; Vallon M; Kosinski C; Zhang JJ; Mah AT; Xu L; Li L; Gholamin S; Reyes TF; Li R; Kuhnert F; Han X; Yuan J; Chiou SH; Brettman AD; Daly L; Corney DC; Cheshier SH; Shortliffe LD; Wu X; Snyder M; Chan P; Giffard RG; Chang HY; Andreasson K; Kuo CJ Nat Med; 2017 Apr; 23(4):450-460. PubMed ID: 28288111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]